A case report of disseminated histoplasmosis and concurrent cryptococcal meningitis in a patient treated with ruxolitinib

BACKGROUND: Ruxolitinib is a highly potent janus kinase inhibitor that places its users at risk for various bacterial infections and viral reactivation. However new reports are also emerging that suggest greater immunosuppression and risk for fungal disease. CASE PRESENTATION: We report the case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Prakash, Katya, Richman, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437885/
https://www.ncbi.nlm.nih.gov/pubmed/30917797
http://dx.doi.org/10.1186/s12879-019-3922-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437885/
https://www.ncbi.nlm.nih.gov/pubmed/30917797
http://dx.doi.org/10.1186/s12879-019-3922-6

Ejemplares similares